Published material on the related Pliva development codes PL-10, PLD-116, and PL-14736 has concentrated on preclinical wound, tissue-protection, and gastrointestinal-injury models rather than randomized human efficacy data, and the peer-reviewed record does not contain a confirmatory efficacy readout for the indications most commonly associated with BPC-157 in informal discussion
The cGMP that is produced via NO activation of soluble guanylate cyclase (sGC) in this tissue is degraded by a specific cyclic nucleotide phosphodiesterase (PDE) identified as PDE5A
Kholodenko et al
R, Naureen B
It adds that regular monitoring is what helps distinguish medication and weight-related effects from underlying thyroid pathology, which is why baseline labs before starting are emphasized
Vukojevic J, Milavi M, Perovi D, Ili S, ili AZ, Duran N, et al